Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 04/25/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol Myers Squibb Merck & Co., Inc. Nektar Therapeutics |
None | None | None | 03/26/2024 |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) Regeneron Pharmactcls |
Regeneron Pharmactcls | None | None | 03/05/2024 |
| Sarah Bateni MAS,MD | None | None | None | None | 03/20/2024 |
| Joel Baumgartner MD | None | None | None | None | 02/05/2024 |
| Shailender Bhatia MD | EMD Serono Incyte Corporation |
Bristol Myers Squibb Incyte Corporation |
None | None | 02/21/2024 |
| Christopher Bichakjian MD | None | None | None | None | 01/24/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Genevieve Boland PhD,MD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. Teiko |
Ankyra Therapeutics InterVenn Biosciences Iovance pharmaceuticals Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
None | Ankyra | 12/20/2023 |
| Sunandana Chandra MS,MD | Alkermes Bristol Myers Squibb Merck & Co., Inc. Novartis Pharmaceuticals Corporation Regeneron Pharmactcls |
Bristol Myers Squibb Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmactcls |
None | None | 04/21/2024 |
| Bartosz Chmielowski PhD,MD | Adagene Advenchen Laboratories Ascentage ATRECA Bristol Myers Squibb Compugen Delcath IDEAYA Biosciences Immunocore Infinity Pharmaceuticals, Inc InstilBio Karyopharm Therapeutics Kezar Life Sciences Kinnate Macrogenics Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation PACT Pharma RAPT Therapeutics Replimune Trisalus Xencor Xilio |
Atreca Expert Witness Replimune |
None | None | 03/20/2024 |
| Dominick DiMaio MD | None | None | None | None | 01/29/2024 |
| Roxana Dronca MD | Alkermes Bristol Myers Squibb Emerson Collective Phosplatin Therapeutics Regeneron Pharmactcls Sorento Therapeutics |
Elsevier, Inc. | None | None | 11/27/2023 |
| Sara Espinosa PhD | None | None | None | None | 04/01/2024 |
| Ryan Fields MD | None | None | None | None | 04/08/2024 |
| Martin Fleming MD,FACS | None | None | None | None | 05/26/2023 |
| Anjela Galan MD | None | None | None | None | 04/15/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | 04/19/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Laura Hanisch PsyD | None | None | None | None | 12/12/2023 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| John Hyngstrom MD | Amgen Inc. Bristol Myers Squibb Checkmate Iovance pharmaceuticals Lokon Lyell Merck & Co., Inc. Morphogenesis Naterra National Cancer Institute Oncosec Philogen SkylineDX |
None | None | None | 03/21/2024 |
| Douglas Johnson MSCI,MD | None | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Teiko |
None | Patent for MHC-II as a biomarker for immunotherapy response|Patient for abatacept or belatacept as treatment for refractory irAEs | 03/04/2024 |
| Madeline Joyce OCN,RN,BSN | None | None | None | None | 03/28/2024 |
| Giorgos Karakousis MD | Merck & Co., Inc. | Bristol Myers Squibb Merck & Co., Inc. |
None | None | 12/28/2023 |
| Ann Karosas RPh,BCOP | None | None | None | None | 02/26/2024 |
| Kari Kendra PhD,MD | Bristol Myers Squibb checkmate pharmaceuticals GSK Immunocore medspace Melanoma Research Foundation Merck & Co., Inc. National Institute on Aging Regeneron Pharmaceuticals, Inc. Varian Medical Systems |
None | None | None | 11/03/2023 |
| Maija Kiuru PhD,MD | CalDerm NanoString Technologies, Inc. National Institute of Arthritis and Musculoskeletal and Skin Diseases NCI NIH UC Davis |
None | None | None | 02/01/2024 |
| Julie Lange ScM,MD | None | None | None | None | 03/04/2024 |
| Ryan Lanning PhD,MD | None | None | None | None | 01/03/2024 |
| Theodore Logan MD,FACP | Abbott Laboratories Abraxis Bioscience, Inc. Acceleron Pharma, Inc. Amgen Inc. Argos Therapeutics AstraZeneca Pharmaceuticals LP AVEO Pharmaceuticals, Inc. Bristol Myers Squibb Cerulean Pharma Dynavax Technologies Eisai Inc. Eli Lilly and Company EMD Serono GSK Immatics Iovance pharmaceuticals MacroGenics MedImmune Inc. Merck & Co., Inc. Millennium Pharmaceuticals, Inc. NiKang Therapeutics Novartis Pharmaceuticals Corporation Peloton Therapeutics, Inc. Pfizer Inc. Prometheus Roche Laboratories, Inc. sanofi-aventis U.S. Synta Pharmaceuticals Corp. Threshold Pharmaceuticals TRACON Pharmaceuticals, Inc. |
None | None | None | 03/16/2024 |
| Miguel Materin MD | None | AstraZeneca Pharmaceuticals LP Castle Biosciences Ideaya Biosciences |
None | None | 01/05/2024 |
| Christine McLaughlin | None | None | None | None | 03/28/2024 |
| Nicole McMillian MS | None | None | None | None | 04/22/2024 |
| Daniel Olson MD | Astellas Pharma US, Inc. Bayer HealthCare Immunocore Inhibrix Takeda Pharmaceuticals North America, Inc. |
Alphinsights Expert Connect GLG Consulting Novartis Pharmaceuticals Corporation Obsidian |
None | None | 02/21/2024 |
| Anthony Olszanski MD,RPh | Antegene GSK HiFiBio Kezar Lantern NeoImmune Pfizer Inc. Regeneron Pharmactcls Shionogi Springbank Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb OncoSec Pfizer Inc. Replimune |
None | None | 12/15/2023 |
| Patrick Ott PhD,MD | Agenus Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Xencor |
Abalos Genentech, Inc. Immunetune Imunon Merck & Co., Inc. Pharmajet Phio |
None | None | 02/01/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
None | None | 10/10/2023 |
| Luke Rothermel MD,MPH | None | None | None | None | 03/20/2024 |
| April Salama MD | Ascentage Bristol Myers Squibb Ideaya Immunocore Merck & Co., Inc. Olatec Regeneron Pharmactcls Replimune SeaGen |
Bristol Myers Squibb Pfizer Inc. Regeneron Pharmaceuticals, Inc. Replimune |
None | None | 04/19/2024 |
| Rohit Sharma MD | None | None | None | None | 12/22/2023 |
| Arun Singh MD | Castle Bisosciences | AURA ISOAID LLC |
Immunocore | None | 03/18/2024 |
| Joseph Skitzki MD | None | None | None | None | 04/22/2024 |
| Andrew Stacey MS,MD | None | None | None | None | 01/12/2024 |
| Susan Swetter MD | None | None | None | None | 01/29/2024 |
| Katy Tsai MD | ABM Therapeutics AstraZeneca Pharmaceuticals LP BioAtla Bristol Myers Squibb Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec OnKure Pfizer Inc. Replimune |
None | None | None | 06/06/2023 |
| Evan Wuthrick MD | None | MyCareGorithm Teiko |
None | None | 09/25/2023 |
| Yan Xing PhD,MD | None | None | None | None | 02/29/2024 |